Nathalie Chauret
Corporate Officer/Principal bei BELLUS HEALTH
Ursprung des Netzwerks ersten Grades von Nathalie Chauret
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 27 | |
Gladius Pharmaceuticals, Inc.
 Gladius Pharmaceuticals, Inc. BiotechnologyHealth Technology Gladius Pharmaceuticals, Inc. operates as a biotechnology company. It develops novel drugs to treat multi-drug-resistant bacterial infections. The company was founded by Larry D. Sutton and is headquartered in Montréal, Quebec.
4
| Private Company | Biotechnology | 4 |
Gladius Pharmaceuticals Corp.
 Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Gladius Pharmaceuticals Corp. operates as a biotechnology firm. The company is headquartered in Wilmington, DE.
3
| Subsidiary | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nathalie Chauret
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Director/Board Member | |
| MOLSON COORS BEVERAGE COMPANY | Beverages: Alcoholic | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Tafkak, Inc.
 Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ALZHEON, INC. | Biotechnology | Director/Board Member Founder | |
| University of Virginia | College/University | Corporate Officer/Principal | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Nemours Foundation
 The Nemours Foundation Investment Trusts/Mutual FundsMiscellaneous The Nemours Foundation is a pediatric health system is engaged in activities that promote higher standards of children's health. It offers a spectrum of clinical treatment, research, advocacy, and educational health and prevention services extending to families in the communities it serves. Nemours Foundation was founded in Alfred I. duPont in 1936. Its headquarters are located in Jacksonville, FL. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Picchio Pharma, Inc.
 Picchio Pharma, Inc. Pharmaceuticals: GenericHealth Technology Picchio Pharma, Inc. engages in acquiring, developing, and commercializing new therapeutic products and technologies. The company was founded in 2001 and is headquartered in Laval, Canada. | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Medical Research Group, Inc.
 Medical Research Group, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medical Research Group, Inc. is a company that designs and develops implantable technologies related to pumps and sensors used for the treatment of diabetes. The company is based in Sylmar, CA. The company was founded by Aaron Mendelsohn, Alfred E. Mann. Medical Research Group was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on August 28, 2001 for $400 million. | Medical Specialties | Corporate Officer/Principal | |
Advanced Bioconcept Ltd.
 Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of Nen Tm Life Science Products, Inc., Advanced Bioconcept Ltd. is a Canadian company that makes proprietary, fluorescent labeled peptides. The company is based in Montréal, Canada. The company was founded by Clarissa Desjardins. Advanced Bioconcept was acquired by Nen Tm Life Science Products, Inc. on September 25, 1998. | Electronic Equipment/Instruments | Founder | |
| McGill University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| SUVEN LIFE SCIENCES LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree Doctorate Degree | |
| University of Montréal | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Georgetown University | College/University | Undergraduate Degree | |
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Sherbrooke | College/University | Doctorate Degree Undergraduate Degree | |
| University of the Witwatersrand | College/University | Doctorate Degree | |
| University of Charles | College/University | Doctorate Degree | |
| THALLION PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
La Fondation de l'innovation du Nouveau-Brunswick
 La Fondation de l'innovation du Nouveau-Brunswick Investment ManagersFinance La Fondation de l'innovation du Nouveau-Brunswick is an Independent Venture Capital firm founded in 2003. La Fondation de l'innovation du Nouveau-Brunswick is headquartered in Fredericton. | Investment Managers | Director/Board Member | |
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
Prognomix, Inc.
 Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Pharmaceuticals: Generic | Chairman Corporate Officer/Principal | |
| Astra Zeneca Pharmaceuticals Philippines, Inc. | Corporate Officer/Principal | ||
Ordre des comptables professionnels agréés du Québec
 Ordre des comptables professionnels agréés du Québec Miscellaneous Commercial ServicesCommercial Services Ordre des comptables professionnels agréés du Québec provides financial services. It offers services related to assurance, financial & management accounting, and taxation. The company was founded in 2012 and is headquartered in Montreal, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Cepmed | Director/Board Member Chief Executive Officer | ||
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder | |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
Find Therapeutics
 Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Biotechnology | Chairman Chief Executive Officer | |
Congruence Therapeutics, Inc.
 Congruence Therapeutics, Inc. BiotechnologyHealth Technology Congruence Therapeutics, Inc. operates as a Canadian biotechnology company. The company is based in Westmount, Canada. Congruence Therapeutics was founded in 2021 by Clarissa Desjardins, who has been the CEO since 2021. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Université du Québec à Montréal | College/University | Graduate Degree Undergraduate Degree |
Statistik
International
| Kanada | 26 |
| Vereinigte Staaten | 19 |
| Vereinigtes Königreich | 3 |
| Indien | 2 |
| Südafrika | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 13 |
| Commercial Services | 9 |
| Finance | 3 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 171 |
| Corporate Officer/Principal | 69 |
| Independent Dir/Board Member | 43 |
| Chairman | 27 |
| Chief Executive Officer | 21 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Franklin Berger | 41 |
| Chau Khuong | 38 |
| Francesco Bellini | 27 |
| Pierre Larochelle | 26 |
| Daniel Hetu | 21 |
| Paul Truex | 17 |
| Youssef Bennani | 17 |
| Vikas Goyal | 16 |
| Joseph Rus | 16 |
| Clarissa Desjardins | 12 |
| Murielle Lortie | 11 |
| Andreas Orfanos | 10 |
| Martin Tolar | 10 |
| Catherine Bonuccelli | 10 |
| Amit K Shah | 9 |
- Börse
- Insiders
- Nathalie Chauret
- Unternehmensverbindungen
